Based on ECHO Phase III trial which demonstrated Calquence combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
ALS patients experience neuroinflammation and rapid neurodegeneration
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
The approval further adds to Biocon’s portfolio of complex drug products
Subscribe To Our Newsletter & Stay Updated
